Identification | Back Directory | [Name]
N-[[4-(5-bromopyrimidin-2-yl)oxy-3-methyl-phenyl]carbamoyl]-2-dimethyl amino-benzamide | [CAS]
134742-19-1 | [Synonyms]
NSC639829 N-[[4-(5-bromopyrimidin-2-yl)oxy-3-methyl-phenyl]carbamoyl]-2-dimethyl amino-benzamide N-[[[4-[(5-Bromo-2-pyrimidinyl)oxy]-3-methylphenyl]amino]carbonyl]-2-(dimethylamino)benzamide Benzamide, N-[[[4-[(5-bromo-2-pyrimidinyl)oxy]-3-methylphenyl]amino]carbonyl]-2-(dimethylamino)- | [Molecular Formula]
C21H20BrN5O3 | [MDL Number]
MFCD00899620 | [MOL File]
134742-19-1.mol | [Molecular Weight]
470.32 |
Hazard Information | Back Directory | [Uses]
NSC-639829 is a Benzoylphenylurea (BPU) analogue which has antitumor activity. NSC-639829 is promising for research of refractory metastatic cancer[1]. | [References]
[1] Hallur G, et al. Benzoylphenylurea sulfur analogues with potent antitumor activity. J Med Chem. 2006 Apr 6;49(7):2357-60. DOI:10.1021/jm051261s |
|
|